Singapore Pharmacy Council CPE: 50 Points, Two-Year Period

Singapore's pharmacists work to a continuing professional education requirement that is easy to state and easy to get wrong. The headline is 50 CPE points. The requirement is not annual, the points are not interchangeable, and the two-year block they sit in does not map onto the practising certificate it supports in the way most people assume.

Fifty points across a two-year qualifying period

The Singapore Pharmacy Council sets the requirement at 50 CPE points for a qualifying period, and the qualifying period runs for two years rather than one. A pharmacist who divides 50 by two and plans 25 points a year will be compliant, but nothing obliges them to spread it that way: the obligation attaches to the block.

The practical trap is the lag between the qualifying period and the certificate it supports. The qualifying period running from 1 September 2024 to 31 August 2026 is the one that underpins practising certificates for 2027 and 2028. Points earned now are not evidencing the certificate currently in force; they are evidencing one that has not been issued yet. A pharmacist who checks their points total against the year printed on the certificate in their hand is reading the wrong window, and an employer tracking staff compliance against the current calendar year is doing the same thing at scale.

At least fifteen points must be patient-care related

Of the 50 points, a minimum of 15 must be patient-care related. That sub-quota is the part that determines what a pharmacist can actually count, and it is the part a training catalogue most often fails to address. Material on regulation, management, pharmacy law or professional practice can carry a pharmacist a long way toward 50 while leaving the 15-point floor untouched.

The planning unit is therefore two running totals, not one. A pharmacist tracking a single number of 50 can arrive near the close of a two-year period apparently well ahead and still be short on the sub-quota that is hardest to fill at short notice. The same structural problem appears across the Australian National Boards, where interactive hours, peer consultation hours and board-approved topics are the scarce items rather than the totals, as set out in our guide to why Ahpra CPD hours are not comparable across National Boards.

Provider accreditation here is a regulatory fact, not a marketing claim

This is the point that separates Singapore from most of the markets where the phrase "CPD accredited" is used loosely. The Council maintains a list of accredited CPE providers, and whether an activity comes from a provider on that list bears on whether its points can be claimed. Accreditation is not a badge a training company awards itself; it is a status the regulator confers and publishes.

That makes the question a pharmacist should ask of any course narrower and more answerable than it is elsewhere: not whether the provider describes itself as accredited, but whether it appears on the Council's own list. For a buyer, the same question applies before committing a budget, and it is worth checking rather than assuming, because provider lists change.

How this compares with the rest of the Singapore healthcare workforce

It would be reasonable to assume Singapore applies one model across its registered health professions. It does not. Nurses and midwives in Singapore are on a different footing entirely: the continuing professional education requirement for them is not yet mandatory, with the mandatory scheme taking effect from 2028, as explained in our guide to Singapore nurses' CPE and what changes in 2028. A pharmacist and a nurse working in the same Singapore hospital today face materially different obligations.

The contrast with the region is sharper still. In Malaysia, CPD for doctors is tied directly to the issue of the annual practising certificate, with a lookback window that catches practitioners who assume the current year counts, as set out in our guide to the Malaysian Medical Council's CPD requirement as an APC prerequisite. The Singapore pharmacy model shares that certificate linkage but places the evidence in a two-year block rather than a single year, which changes both the cadence of demand and the way a shortfall surfaces.

Why a two-year block hides a shortfall for longer

An annual requirement has one useful property: it surfaces a problem every twelve months. A two-year block does not. A pharmacist can sit twenty-three months into a qualifying period, well short on the patient-care sub-quota, without anything in the system having flagged it, because the obligation has not yet fallen due.

The lag between the qualifying period and the certificate it supports makes that worse rather than better. Points earned after a qualifying period closes belong to the next period. They cannot be applied retrospectively to the window that has just ended, so a shortfall discovered at the close of a period cannot be fixed inside the period it was meant to evidence. The only effective defence is to track both running totals from the first month of the block rather than the last, and for an employer, to hold those two figures per pharmacist rather than one combined number.

What to verify before relying on any of this

Qualifying period dates roll, point requirements are reviewed, and accredited provider lists are updated. Any figure here should be checked against the Council's current published requirements and its current provider list on the Health Professionals Portal, which hosts the Singapore Pharmacy Council's pages, before being used for a renewal or procurement decision. The structural points — the two-year block, the lag to the certificate, the patient-care sub-quota and the accredited provider list — are the durable part. The dates are not.